I et klinisk forsøg medførte indgivelse af Kepivance inden for 24 timer fra kemoterapi en øget grad og varighed af oral mucositis.
In a clinical trial, administration of Kepivance within 24 hours of chemotherapy resulted in an increased severity and duration of oral mucositis.